Joel Block to Tumor Necrosis Factor-alpha
This is a "connection" page, showing publications Joel Block has written about Tumor Necrosis Factor-alpha.
Connection Strength
0.712
-
New therapeutic approaches for spondyloarthritis. Curr Opin Rheumatol. 2007 May; 19(3):259-64.
Score: 0.269
-
Drug-induced systemic lupus erythematosus associated with etanercept therapy. Lancet. 2002 Feb 16; 359(9306):579-80.
Score: 0.187
-
Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade. Am J Ther. 2008 Jan-Feb; 15(1):53-8.
Score: 0.070
-
Etanercept therapy in patients with a positive tuberculin skin test. Clin Exp Rheumatol. 2007 Sep-Oct; 25(5):743-5.
Score: 0.069
-
The treatment of psoriatic arthritis. Am J Ther. 2006 Jan-Feb; 13(1):72-9.
Score: 0.061
-
Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis. 2004 Aug 01; 39(3):295-9.
Score: 0.055